Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “insulin”

91 pharma patents match "insulin" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 91
Index total 30,257
Page 3 / 4

Quick answer

This filtered view shows 91 pharmaceutical patents matching "insulin" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

91 results for “insulin” · 30,257 patents in full index Clear search

  1. US 8900555

    Insulin derivative formulations for pulmonary delivery

    Nektar Therapeutics · Granted Dec 2, 2014 · Expires Nov 27, 2034

    granted
  2. US 8858950

    Delivery of pharmaceutical agents via the human insulin receptor

    The Regents of the University of California · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted
  3. US 8809269

    Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  4. US 8685403

    Insulin-like growth factor signaling and integrin

    The Regents of the University of California · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted
  5. US 8673964

    Use of drug combinations for treating insulin resistance

    DiaMedica Inc. · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted
  6. US 8568713

    Super fast-acting insulin compositions

    HALOZYME, INC. · Granted Oct 29, 2013 · Expires Oct 24, 2033

    granted
  7. US 8318154

    Super fast-acting insulin compositions

    HALOZYME, INC. · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted
  8. US 8263095

    Methods of use for peptides having activities of insulin like growth factor-1

    CAREGEN CO., LTD. · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  9. US 8168391

    Method for modulating insulin production

    The Regents of the University of California · Granted May 1, 2012 · Expires Apr 26, 2032

    granted
  10. US 8163509

    Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  11. US 8071323

    Human monoclonal antibodies that bind human insulin like growth factors and their use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  12. US 8034556

    Regulation of glucose and insulin levels by GnT-4 glycosyltransferase activity

    The Regents of the University of California · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted
  13. US 7803940

    Heteromonocyclic compound or a salt thereof having strong antihypertensive action, insulin sensitizing activity and the like production thereof and use thereof for prophylaxis or treatment of cardiovascular diseases, metabolic diseases and/or central nervous system diseases

    Takeda Pharmaceutical Company Limited · Granted Sep 28, 2010 · Expires Sep 23, 2030

    granted
  14. US 7749720

    Methods of identifying compounds for producing insulin sensitization

    The Regents of the University of California · Granted Jul 6, 2010 · Expires Jul 1, 2030

    granted
  15. US 7700128

    Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester

    Takeda Pharmaceutical Company Limited · Granted Apr 20, 2010 · Expires Apr 15, 2030

    granted
  16. US 7651845

    Method and apparatus for glucose control and insulin dosing for diabetics

    The Regents of the University of California · Granted Jan 26, 2010 · Expires Jan 21, 2030

    granted
  17. US 7629168

    Insulin expressing human pancreatic islet cell line capable of reversibly proliferating and use thereof

    Kuraray Medical Inc. · Granted Dec 8, 2009 · Expires Dec 3, 2029

    granted
  18. US 7622447

    Use of glutathione synthesis stimulating compounds in reducing insulin resistance

    DiaMedica Inc. · Granted Nov 24, 2009 · Expires Nov 19, 2029

    granted
  19. US 7556926

    Methods for screening insulin-sensitizing agents

    Takeda Pharmaceutical Company Limited · Granted Jul 7, 2009 · Expires Jul 2, 2029

    granted
  20. US 7410641

    Antibodies to insulin/IGF/relaxin family polypeptides

    Takeda Pharmaceutical Company Limited · Granted Aug 12, 2008 · Expires Aug 7, 2028

    granted
  21. US 7388079

    Delivery of pharmaceutical agents via the human insulin receptor

    The Regents of the University of California · Granted Jun 17, 2008 · Expires Jun 12, 2028

    granted
  22. US 7323165

    Production of pancreatic islet cells and delivery of insulin

    The Regents of the University of California · Granted Jan 29, 2008 · Expires Jan 24, 2028

    granted
  23. US 7173005

    Insulin and IGF-1 receptor agonists and antagonists

    ANTYRA INC. · Granted Feb 6, 2007 · Expires Feb 1, 2027

    granted
  24. US 7056734

    Differentiation of non-insulin producing cells into insulin producing cells by GLP-1 or exendin-4 and uses thereof

    The United States of America, as represented by the Department of Health and Human Services, N.I.H. · Granted Jun 6, 2006 · Expires Jun 1, 2026

    granted